|
Accueil > Actualité
Abbott Labs: annual EPS range tightened
(CercleFinance.com) - Abbott Laboratories has tightened its 2024 adjusted EPS target range to $4.
64-4.70 from $4.61-4.71, on organic sales growth (excluding Covid-19 revenues), which is still expected at 9.5%-10%. For Q3 2024, the healthcare group reports adjusted EPS of $1.21, on revenues that are up 4.9% to $10.6bn, still driven by its underlying core business. On an organic basis and excluding sales linked to Covid-19 tests, sales rose by 8.2%, notably driven by double-digit growth in medical devices (+13.3%) and especially diabetes care (+19.1%). Copyright (c) 2024 CercleFinance.com. All rights reserved. |
16/05/2025 17:23
Walmarten vert après ses résultats, un broker à l'achat 16/05/2025 16:41 Merckva présenter ses avancées dans l'hypertension (HTAP) 16/05/2025 16:29 KKRaccord avec Inhabeo pour financer un campus étudiant 16/05/2025 15:55 UbisoftDWS Investment passe sous les 5% du capital 16/05/2025 15:00 Take-Twolourde perte sur des dépréciations au 4e trimestre 16/05/2025 14:41 Teslal'ancien directeur financier de Chipotle au conseil Tous les articles sociétés |
